Michelle Moser

Contributor

tags: Biologics Biopharma news CROs MedChem Pharma 4.0 Pharmaceutical industry trends Pharmaceutical Marketing Small Molecules Biomedical Research Biotech Research Clinical Trials Drug Discovery and Development Medicinal Chemistry Pharma Regulations and Legal Aspects Pharmaceutical Manufacturing

Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.

CD BioSciences, a professional US provider of integrated solutions for clinical trials development, has introduced first-in-human (FIH) study service to biological and pharmaceutical institutes and companies for drug development needs.

Michelle Moser

Posts by this author

CD BioSciences Introduces First-in-Human (FIH) Study Service for Clinical Trials